Mar 04, 2021 / 02:10PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good morning and welcome to the Eli Lilly's session of Cowen's 41st Annual Healthcare Conference. We're very pleased to have with us today, Dr. Dan Skovronsky, who is Senior Vice President and Chief Scientific Officer.
Cowen has been recommending Lilly's stock now since 2014, and it has been a great stock because great companies tend to be great stocks. And great companies are led by great leaders. And we have one of those great leaders here today. So Dan, thank you for your time.
Daniel M. Skovronsky - Eli Lilly and Company - Senior VP, Chief Scientific Officer & President of Lilly Research Labs
Thank you, Steve.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystMaybe we could start out by talking about tirzepatide because of the data that was just issued this morning, the SURPASS-2 data. Maybe you could just take a moment to